H077 sustained-release tablets

· Shanghai Huilun Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for H077 sustained-release tablets, covering 2025-08-28 to 2025-08-28. Get the full timeline:

Most recent: Clinical Trial Update: A Phase III Clinical Study of H077 Sustained-Release Tablets Compared With Silodosin Capsules in the Treatment of Benign Prostatic Hyperplasia [Phase 3]

See pricing